Arglabin, an EGFR Receptor Tyrosine Kinase Inhibitor, Suppresses Proliferation and Induces Apoptosis in Prostate Cancer Cells

Arglabin, a sesquiterpene lactone isolated from Artemisia glabella, was cytotoxic to different human cancer cell lines including those derived from advanced triple-negative breast, lung, and androgen-dependent and androgen-independent prostate carcinomas.